Active, not recruitingPhase 2NCT04713514
OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC
Studying Best vitelliform macular dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- ARCAGY/ GINECO GROUP
- Principal Investigator
- Alexandra LEARY, MD,PHDGINECO - Gustave Roussy
- Intervention
- OSE2101(drug)
- Enrollment
- 180 target
- Eligibility
- 18 years · FEMALE
- Timeline
- 2021 – 2025
Study locations (30)
- UZ Leuven, Leuven, Belgium
- Centre Hospitalier de l'Ardenne Vivalia, Libramont, Belgium
- Centre Hospitalier Universitaire de Liège, Liège, Belgium
- ICO Paul Papin, Angers, France
- Institut du Cancer Avignon-Provence, Avignon, France
- Centre Hospitalier de la Côte Basque, Bayonne, France
- CHU Besançon - Hôpital Jean Minjoz, Besançon, France
- Institut Bergonié, Bordeaux, France
- Centre François Baclesse, Caen, France
- Centre d'Oncologie et de Radiothérapie 37, Chambray-lès-Tours, France
- Centre Hospitalier de Cholet, Cholet, France
- Centre Jean PERRIN, Clermont-Ferrand, France
- Centre Georges François Leclerc, Dijon, France
- CHU Grenoble-Alpes - Site Nord (La Tronche), Grenoble, France
- Centre Oscar Lambret, Lille, France
- +15 more locations on ClinicalTrials.gov
Collaborators
OSE Immunotherapeutics · Merck Sharp & Dohme LLC
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04713514 on ClinicalTrials.govOther trials for Best vitelliform macular dystrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07171554Evaluation of a Diagnostic Test to Identify the Best Drugs for Treatment of Metastatic Colorectal CancerOncosyne AS
- RECRUITINGNANCT07234409Clinical Trial Addressing the Best Surgical Approach for Partial Nephrectomy With Single Port Robotic System in the Management of Localized Renal Cell CarcinomaNiguarda Hospital
- RECRUITINGNANCT07281092Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)Seattle Children's Hospital
- RECRUITINGPHASE1, PHASE2NCT07185256Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)Opus Genetics, Inc
- RECRUITINGNCT06805474A Prospective Observational Study to Assess the Reliability and Validity of the MLSDTNanoscope Therapeutics Inc.
- RECRUITINGNANCT06899399Efficacy and Safety Study of Endovascular Treatment of Asymptomatic Carotid Artery StenosisBeijing Tiantan Hospital
- ACTIVE NOT RECRUITINGNANCT05802940Low Dose Aspirin Alerts in High-Risk PregnanciesGeisinger Clinic
- RECRUITINGNANCT05737407Lung Ultrasound Guided Choice of Best Positive End-Expiratory Pressure in Neonatal AnesthesiaVittore Buzzi Children's Hospital